Cefrobact-CL 375 Tablet
strip of 6.0 tablets.Prescription required
About this product:
| Salt Composition: | Cefuroxime (250mg) + Clavulanic Acid (125mg) |
| Manufacturer: | Abia Pharmaceuticals Pvt. Ltd. |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Cefrobact-CL 375 Tablet is a combination medicine that is used to treat various types of bacterial infections. It fights against the microorganisms to prevent their growth and further spread of the infection. Cefrobact-CL 375 Tablet is a prescription medicine. It is advised to take it as per the prescription. It can be taken with or without food but it must be taken at a fixed time to ensure better efficacy. Do not consume more than the recommended dose as this may have harmful effects on your body. If you miss a dose take it as soon as you remember. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine.
Cefrobact-CL 375 Tablet is a combination of two medicines: Cefuroxime and Clavulanic Acid. Cefuroxime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Clavulanic Acid is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate Cefuroxime. Addition of Clavulanic Acid reduces resistance and enhances the activity of Cefuroxime against bacteria.
Can Cefrobact-CL 375 Tablet be used to treat viral infections?
No, Cefrobact-CL 375 Tablet is only indicated for treating bacterial infections. It does not treat viral infections such as the common cold or flu.
What are the contraindications associated with the use of Cefrobact-CL 375 Tablet?
Individuals with known allergies to any components of this medication should avoid its use. It is crucial to inform your healthcare provider about your medical history before taking the medicine to prevent potential adverse effects.
Can the use of Cefrobact-CL 375 Tablet cause diarrhea?
Yes, Cefrobact-CL 375 Tablet can cause diarrhea. Antibiotics can disrupt the balance of bacteria in the digestive system and lead to diarrhea. If you experience diarrhea, drink plenty of fluids, and consult your doctor if the diarrhea persists. It is crucial not to self-medicate with any other medication without first consulting a healthcare professional.
Can I stop taking Cefrobact-CL 375 Tablet when I feel better?
No, do not stop taking Cefrobact-CL 375 Tablet and complete the full course of treatment even if you feel better. Your symptoms may improve before the infection is completely cured.
What are the instructions for the storage and disposal of Cefrobact-CL 375 Tablet?
Store Cefrobact-CL 375 Tablet in its original packaging, keeping it tightly sealed. Follow the instructions provided on the packaging or label for safe storage. Dispose of unused medication properly. Ensure that this medicine is inaccessible to pets, children, and other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Cefrobact-CL 375 Tablet may be taken with or without food but it is better to take it at a fixed time.
- Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic.
- Stop taking Cefrobact-CL 375 Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.
- No common side effects listed.
Alcohol
Consuming alcohol with Cefrobact-CL 375 Tablet does not cause any harmful side effects.
Breastfeed
Cefrobact-CL 375 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Cefrobact-CL 375 Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
